In the Chinese medical devices industry, there were ten M&A deals announced in Q3 2024, worth a total value of $41.1m, according to GlobalData’s Deals Database. The $16.5m minority acquisition of Sichuan Jiuyiyuan Particle Technology by Shanghai United Imaging Healthcare was the industry’s largest disclosed deal. GlobalData’s ³Ô¹ÏºÚÁÏÍøs Industry Mergers and Acquisitions Deals by Top Themes in Q3 2024 report helps understand the pivotal themes steering M&A activity in the industry.

Smarter leaders trust GlobalData

Data Insights

Data Insights

The gold standard of business intelligence.

Find out more

In value terms, M&A activity in China decreased by 19% in Q3 2024 compared with the previous quarter’s total of $50.8m and fell by 71% as compared to Q3 2023. Related deal volume increased by 150% in Q3 2024 versus the previous quarter.

For further understanding of GlobalData's ³Ô¹ÏºÚÁÏÍøs Industry Mergers And Acquisitions Deals By Top Themes In Q3 2024 – Strategic Intelligence,

This content was updated on 19 October 2024

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Deals Database tracks global deal activity, including mergers, acquisitions, capital raising, strategic alliances, and licensing agreements. Proprietary analysis is used to group deals into key thematic areas and granular sectors across the world’s largest industries.

This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Deal type includes Acquisition, Asset transactions and Mergers.